It’s a problem as old and as aggravating as eye drops themselves: as soon as the medicine goes in, almost all of it washes right back out again.
Now, McMaster chemical engineer Heather Sheardown and the graduate students in her lab have developed a better way to deliver medicine to the surface of the eye.
They have created microscopic packets of medicine that lodge themselves imperceptibly in the base of the tear film that makes up the wet surface of the eye.
There, the molecular packets, or depots, dissolve gradually, releasing medicine slowly and making it possible for people with conditions such as dry eye and glaucoma – which require daily drops – to receive the same degree of treatment from using drops just once a week.
Sheardown, a Canada Research Chair in Ophthalmic Biomaterials and Scientific Director of the 20/20 NSERC Ophthalmic Materials Research Network, says that partners in the field had named the problem with conventional eye drops as one of the top issues in all of eye care.
The problem is that the eye does a good job of defending itself against foreign substances, making it difficult for the active ingredients in eye drops to do their work before the eye sheds them.
With conventional drops, 95 per cent of the medicine is typically lost before it has a chance to work, a frustrating inefficiency, especially for patients.
“It’s a lousy delivery system,” Sheardown says. “If you can deliver drops to the front of the eye at lower concentrations that work over a longer period, it could be huge.”
Sheardown’s team is in the final stages of proving the safety and effectiveness of the new technology, which was described recently in the journal Biomacromolecules. The research was funded by the 20/20 NSERC Ophthalmic Materials Research Network and The Boris Family Foundation.
Sheardown is presenting the new technology to the Tear Film and Ocular Surface Society in France in September.
She says there has been interest in commercializing the technology, and she hopes it will be on the market in the near future.
Learn more: NO LONGER LOST IN THE BLINK OF AN EYE
The Latest on: Eye drop drug delivery
via Google News
The Latest on: Eye drop drug delivery
- Retinal drug delivery using eyedrop preparations of poly-L-lysine-modified liposomes. on March 28, 2019 at 5:00 pm
The purpose of this study was to develop surface-modified liposomes that enhance the efficiency of eye drop drug delivery to the retina. Various molecular weights and concentrations of the ... […]
- Microneedle contact lens targets the eye for drug delivery on November 19, 2018 at 2:33 am
When tested on mice with corneal vascularisation, a single application of the patch was 90 per cent more effective in alleviating the condition than applying a single eye drop with 10 times more drug ... […]
- Medical research: An eye patch for drug delivery on November 6, 2018 at 6:02 pm
The microneedles dissolve over time, slowly releasing the drug ... that delivery of the monocolonal antibody DC101 using the eye patch achieved about a 90% reduction in the neovascular area with a ... […]
- OcuMedic, Inc. Granted European Patent for Contact Lens Drug Delivery System on November 5, 2018 at 6:58 am
All patients require post-operative care, which includes eye drops that can wash out quickly ... Inc. is the developer of the world’s first, drug-eluting therapeutic lens/clear corneal bandage for the ... […]
- Eye hospital nets patent for innovative drug delivery on May 10, 2018 at 12:30 pm
TIRUNELVELI: The Tirunelveli branch of Dr Agarwal’s Eye Hospital has obtained a patent for an innovative drug delivery technique to effectively ... corneal diseases is by fortified antibiotic eye ... […]
- Ophthalmic Drug-Delivery Device Improves Patient Experience on December 3, 2017 at 4:00 pm
Aero Pump GmbH’s preservative-free Multidose Eye Dropper ... meters an exact drop size. Pharmaceutical Technology spoke with Rouven Kraus, International Sales with Aero Pump, about this innovation and ... […]
- Scientists engineer drug delivery device that treats glaucoma directly inside the eye on November 22, 2017 at 4:00 pm
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used ... PhD student in the Desai Lab. Drug implant dissolves to treat glaucoma Recognizing ... […]
- iVeena Delivery Systems Receives FDA Orphan Drug Designation for IVMED-80 for the Treatment of Keratoconus on November 8, 2017 at 3:00 am
IVMED-80 biomechanically strengthens the cornea through the daily application of a non-invasive, proprietary eye-drop. It has been granted Orphan Drug Designation by the FDA and will begin clinical ... […]
- Creation of nano eye-drops and effective drug delivery to the interior of the eye on March 13, 2017 at 5:00 pm
Nano eye-drops are a new type of ophthalmic treatment with increased potency and reduced side effects. Compounds in conventional eye-drops barely penetrate into the eye because the cornea, located at ... […]
via Bing News